Tang, Jun

Comprehensive analysis of the clinical immuno-oncology landscape

Tang, J., Shalabi, A., & Hubbard-Lucey, V. M. (2018) · Annals of Oncology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 508

The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors

Tang, J., Yu, J. X., Hubbard-Lucey, V. M., Neftelinov, S. T., Hodge, J. P., & Lin, Y. (2018) · Nature Reviews Drug Discovery

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 382

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis

Beldman, T. J., Senders, M. L., Alaarg, A., Pérez-Medina, C., Tang, J., Zhao, Y., Fay, F., Deichmöller, J., Born, B., Desclos, E., et al. (2017) · ACS Nano

Nanoparticle-Based Drug DeliveryAtherosclerosis and Cardiovascular Diseases

Cited by 196

Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis

Seijkens, T. T. P., van Tiel, C. M., Kusters, P. J. H., Atzler, D., Soehnlein, O., Zarzycka, B., Aarts, S. A. B. M., Lameijer, M., Gijbels, M. J., Beckers, L., et al. (2018) · Journal of the American College of Cardiology

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 195

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy

Pérez-Medina, C., Abdel-Atti, D., Tang, J., Zhao, Y., Fayad, Z. A., Lewis, J. S., Mulder, W. J. M., & Reiner, T. (2016) · Nature Communications

Nanoparticle-Based Drug DeliveryRadiopharmaceutical Chemistry and Applications

Cited by 128